Egyptian International Pharmaceutical Industries Company (EGX:PHAR)
Egypt
· Delayed Price · Currency is EGP 50.63
-0.36 (-0.71%)
At close: Mar 27, 2025
EGX:PHAR Balance Sheet
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 1,295 | 675.8 | 482.97 | 311.59 | 732.75 | Upgrade
|
| Cash & Short-Term Investments | 1,295 | 675.8 | 482.97 | 311.59 | 732.75 | Upgrade
|
| Cash Growth | 91.68% | 39.93% | 55.00% | -57.48% | 24.41% | Upgrade
|
| Accounts Receivable | 1,331 | 1,153 | 946.58 | 792.04 | 756.44 | Upgrade
|
| Other Receivables | - | 0.67 | 12.7 | 10.95 | 261.03 | Upgrade
|
| Receivables | 3,049 | 2,359 | 1,807 | 1,172 | 1,137 | Upgrade
|
| Inventory | 3,585 | 2,242 | 2,162 | 1,818 | 1,797 | Upgrade
|
| Other Current Assets | 197.91 | 209.39 | 130.2 | 234.32 | - | Upgrade
|
| Total Current Assets | 8,127 | 5,486 | 4,582 | 3,536 | 3,668 | Upgrade
|
| Property, Plant & Equipment | 6,748 | 4,024 | 1,838 | 1,372 | 1,026 | Upgrade
|
| Long-Term Investments | 465.26 | 466.49 | 352.34 | 326.84 | 339.17 | Upgrade
|
| Other Intangible Assets | 32.05 | 2.3 | 1.57 | - | - | Upgrade
|
| Other Long-Term Assets | - | -0 | - | - | - | Upgrade
|
| Total Assets | 15,373 | 9,979 | 6,774 | 5,235 | 5,033 | Upgrade
|
| Accounts Payable | 381.8 | 138.42 | 185.56 | 60.37 | 96.33 | Upgrade
|
| Accrued Expenses | 184.12 | 100.83 | 88.48 | 63.29 | 19.58 | Upgrade
|
| Short-Term Debt | 4,435 | 2,083 | 2,047 | 1,234 | 1,381 | Upgrade
|
| Current Portion of Leases | 0.3 | 2.19 | 1.39 | - | - | Upgrade
|
| Current Income Taxes Payable | 344.85 | 184.98 | 106.82 | 110.62 | 70.23 | Upgrade
|
| Other Current Liabilities | 540.15 | 321.05 | 230.07 | 192 | 153.43 | Upgrade
|
| Total Current Liabilities | 5,887 | 2,831 | 2,660 | 1,661 | 1,721 | Upgrade
|
| Long-Term Debt | 4,782 | 2,832 | 812.13 | 529.07 | 413.37 | Upgrade
|
| Long-Term Leases | 10.71 | 0.13 | 0.79 | - | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | 35.83 | 54.79 | 58.94 | 71.84 | 51.86 | Upgrade
|
| Total Liabilities | 10,715 | 5,718 | 3,532 | 2,261 | 2,186 | Upgrade
|
| Common Stock | 1,488 | 1,488 | 991.71 | 991.71 | 991.71 | Upgrade
|
| Retained Earnings | 1,904 | 1,508 | 1,286 | 1,047 | 1,070 | Upgrade
|
| Treasury Stock | - | - | - | - | -89.86 | Upgrade
|
| Comprehensive Income & Other | 1,262 | 1,262 | 961.82 | 931.82 | 871.82 | Upgrade
|
| Total Common Equity | 4,654 | 4,257 | 3,239 | 2,971 | 2,844 | Upgrade
|
| Minority Interest | 3.82 | 3.39 | 3.05 | 2.82 | 2.88 | Upgrade
|
| Shareholders' Equity | 4,658 | 4,261 | 3,242 | 2,973 | 2,847 | Upgrade
|
| Total Liabilities & Equity | 15,373 | 9,979 | 6,774 | 5,235 | 5,033 | Upgrade
|
| Total Debt | 9,229 | 4,918 | 2,862 | 1,763 | 1,794 | Upgrade
|
| Net Cash (Debt) | -7,933 | -4,242 | -2,379 | -1,452 | -1,062 | Upgrade
|
| Net Cash Per Share | -53.33 | -28.52 | -23.99 | -14.64 | -10.88 | Upgrade
|
| Filing Date Shares Outstanding | 148.76 | 148.76 | 99.17 | 99.17 | 97.57 | Upgrade
|
| Total Common Shares Outstanding | 148.76 | 148.76 | 99.17 | 99.17 | 97.57 | Upgrade
|
| Working Capital | 2,241 | 2,655 | 1,922 | 1,876 | 1,947 | Upgrade
|
| Book Value Per Share | 31.28 | 28.62 | 32.66 | 29.95 | 29.15 | Upgrade
|
| Tangible Book Value | 4,622 | 4,255 | 3,238 | 2,971 | 2,844 | Upgrade
|
| Tangible Book Value Per Share | 31.07 | 28.60 | 32.65 | 29.95 | 29.15 | Upgrade
|
| Land | 83.19 | 83.19 | 83.19 | - | - | Upgrade
|
| Buildings | 543.43 | 542.86 | 543.84 | - | - | Upgrade
|
| Machinery | 2,158 | 1,983 | 1,892 | - | - | Upgrade
|
| Construction In Progress | 5,694 | 3,058 | 866.16 | - | - | Upgrade
|
Updated Mar 2, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.